Common

Global Coffee Market Size and Forecast Report, 2023-2024 and 2030: Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Retail, Agriculture, Natural Resources, Food, Beverage, Online, Element, Espresso, Consumer, Quality control, Culture, Farmer, Taste, Convenience, Urbanization, Country, Exchange, Nutrient, Coffee, International Coffee Organization, Common, Policy, Seed, Mineral, ICO, Drink, Caffeine, Artificial intelligence, Spice, Instant coffee

The "Global Coffee Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Coffee Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • As per the International Coffee Organization (ICO), global coffee consumption in 2023 reached 175.6 million 60-kg bags, equivalent to approximately 2.25 billion cups daily.
  • Latin America is anticipated to lead the global coffee market mainly owing to the presence of the biggest coffee producer, that is, Brazil.
  • By product type, the global coffee market is fragmented into Instant Coffee, Ground Coffee, Whole Grain, and Others.

Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion

Retrieved on: 
Monday, March 18, 2024
Pharmaceutical, Health, Neurology, Clinical Trials, Depression, Metabolism, Brain, NCE, Acute stress disorder, Concussion, Veterans' affairs, Executive, Common, Inflammation, Patient, United States Congress, TBI, Foundation (nonprofit), Anxiety, CTE, University, Military personnel, Oxidative stress, Human, GMP, Nasal cavity, Traumatic brain injury, DSM-IV codes, Phase, Traffic, Swelling, FDA, Animal, Pentagon, Chronic traumatic encephalopathy, Phase II, Marcus Foundation, Medical device

Oragenics’ lead drug candidate, ONP-002 is combined with its intranasal device intended for the treatment of mild Traumatic Brain Injury (TBI), aka concussion.

Key Points: 
  • Oragenics’ lead drug candidate, ONP-002 is combined with its intranasal device intended for the treatment of mild Traumatic Brain Injury (TBI), aka concussion.
  • Dr. Kelly was also National Director of the Avalon Action Alliance TBI Programs for which the MIBH serves as the clinical coordinating center.
  • “I am excited to join Oragenics as its Chief Medical Officer at such an important and pivotal time in the drug development process.
  • Dr. Kelly has interacted with the FDA and clinical trials for brain injury throughout his esteemed career.

Aeva Technologies, Inc.’s Reverse Stock Split Becomes Effective

Retrieved on: 
Monday, March 18, 2024
Hardware, Automotive, Robotics, Consumer Electronics, Technology, Vehicle Technology, Semiconductor, Other Technology, Transfer, Trust, Common, CUSIP, Sale, Exercise, Security (finance)

Aeva ® (NYSE: AEVA), a leader in next-generation sensing and perception systems, today announced that its previously announced a 1-for-5 reverse stock split of its outstanding shares of common stock became effective as of March 18, 2024 at 4:01 p.m. Eastern Time.

Key Points: 
  • Aeva ® (NYSE: AEVA), a leader in next-generation sensing and perception systems, today announced that its previously announced a 1-for-5 reverse stock split of its outstanding shares of common stock became effective as of March 18, 2024 at 4:01 p.m. Eastern Time.
  • As a result of the reverse stock split, every five issued and outstanding shares of Aeva’s common stock was automatically reclassified into one issued and outstanding share of Aeva’s common stock.
  • The reverse stock split will not affect the number of authorized shares of common stock or the par value of the common stock.
  • The reverse stock split is primarily intended to increase the per share trading price of Aeva’s common stock in order to meet the NYSE’s price criteria for continued listing.

Solo Brands Announces Fourth Quarter and Fiscal Year 2023 Results Provides Full Year 2024 Guidance

Retrieved on: 
Thursday, March 14, 2024
Fashion, Lifestyle, Retail, Consumer, Home Goods, Specialty, Conference, Growth, Three Months, The Twelve Months, Webcast, Common, Line of credit, Acquisition, Depreciation, DTC, Oru, GAAP, Term loan, Marketing, Video game

Solo Brands, Inc. (NYSE: DTC) (“Solo Brands” or “the Company”) today announced its financial results for the three and twelve month periods ended December 31, 2023.

Key Points: 
  • Solo Brands, Inc. (NYSE: DTC) (“Solo Brands” or “the Company”) today announced its financial results for the three and twelve month periods ended December 31, 2023.
  • Lower net sales resulted, in part, from a lack of significant new product launches in the fourth quarter of 2023 when compared to the fourth quarter of 2022.
  • Adjusted net income per Class A common stock(1)(2) was $0.13 per diluted share for the fourth quarter of 2023 compared to $0.25 for the fourth quarter of 2022.
  • A conference call to discuss the Company's fourth quarter and fiscal 2023 results is scheduled for March 14, 2024, at 8:30 a.m.

Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease

Retrieved on: 
Wednesday, March 13, 2024
Science, Other Science, Research, Pharmaceutical, General Health, Health, Genetics, Other Health, Diagnosis, Alnylam Pharmaceuticals, Dizziness, Medication, Learning, Weakness, Genetic testing, Disease, TTR, Risk, Human, Patient, Common, Knowledge, Constipation, Diarrhea, Child, Amyloidosis, MBA, MPH, Heart, RNA interference, Carpal tunnel syndrome, Therapy, Multimedia, Family, Pharmaceutical industry

“Family history is considered one of the most important risk factors for health problems.

Key Points: 
  • “Family history is considered one of the most important risk factors for health problems.
  • “It took seeing nine doctors over seven years for me to finally receive a diagnosis of hATTR amyloidosis,” said Christine, a Family Health History Road Trip participant who is living with hATTR amyloidosis.
  • If I had, I could have potentially been diagnosed and started on a disease management plan much earlier.”
    With an inherited disease like hATTR amyloidosis that progresses rapidly, early diagnosis is crucial.
  • A genetic test can determine whether a person carries one of the more than 120 variants in the TTR gene associated with hATTR amyloidosis.

Biswas Family Foundation, Milken Institute Announce $15 Million in Funding for Research at the Intersection of AI and Health

Retrieved on: 
Tuesday, March 12, 2024
Technology, General Health, Infectious Diseases, Foundation, Philanthropy, Science, Biotechnology, Health, Health Technology, Other Philanthropy, Other Science, Research, Other Technology, Other Health, Pharmaceutical, Artificial Intelligence, Oncology, Gladstone Institutes, Diagnosis, Health informatics, Harvard Medical School, Computational biology, SPARC, Transformative use, Test management, Computer science, Data science, Disease, Assistant, Massachusetts Institute of Technology, Associate, Chatbot, Partnership, Genetics, Patient, Common, Artificial intelligence, AI, Doctor of Philosophy, Interpretation, Investment, Stanford University, Milken Institute, Genetic distance, Medical device

The Biswas Family Foundation , in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) , is pleased to announce the inaugural recipients of the Transformative Computational Biology Grant Program .

Key Points: 
  • The Biswas Family Foundation , in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) , is pleased to announce the inaugural recipients of the Transformative Computational Biology Grant Program .
  • Five multidisciplinary research teams will receive nearly $14 million total in grant funding for projects aiming to drive translational impact and the advancement of artificial intelligence (AI) models in clinical settings for diagnosis and treatment.
  • Additional support to enhance AI and computational biology research, inclusive of a gift to the Arc Institute , marks a total of $15 million in giving for the Biswas Family Foundation for this interdisciplinary field, and the beginning of more support.
  • To learn more about the Transformative Computational Biology Grant Program and to read the Giving Smarter Guide, visit: https://bit.ly/3Vae8Kq .

Rubric Capital Management Nominates Two Highly Qualified, Independent Directors to Xperi Inc. Board of Directors

Retrieved on: 
Monday, March 11, 2024
Asset Management, Professional Services, Finance, Failure, Health, History, Sale, Marketing, Corporation, TSRA, Immersion, INTC, WHEN, Phoenix Technologies, Interim, DSP Group, Common stock, Knowledge, AI, Security (finance), Senior, UPON, Intel, Immersion Corporation, Growth, International Rectifier, Common, Capital, Management

David Rosen, Managing Partner of Rubric, said, “Xperi has built an attractive portfolio of innovative enablement technologies with significant monetization potential.

Key Points: 
  • David Rosen, Managing Partner of Rubric, said, “Xperi has built an attractive portfolio of innovative enablement technologies with significant monetization potential.
  • The participants in the proxy solicitation are anticipated to be Rubric Master, Rubric Capital GP LLC (“Rubric Master GP”), Rubric Capital Management LP (“Rubric Capital”), Rubric Capital Management GP LLC (“Rubric Capital GP”), David Rosen, Deborah S. Conrad and Thomas A. Lacey.
  • As of the date hereof, 625,756 shares of Common Stock are held in certain accounts managed by Rubric Capital (the “Rubric Accounts”).
  • Rubric Capital GP, as the general partner of Rubric Capital, may be deemed the beneficial owner of the 4,043,744 shares of Common Stock owned in the aggregate by Rubric Master and held in the Rubric Accounts.

Cancellation of Takeaway Orders Increases in the Last Hour of Restaurant Operation

Retrieved on: 
Monday, March 11, 2024
Restaurant, Bar, Food, Beverage, Retail, Apps, Applications, Technology, Just Eat, Otter, Uber Eats, Common, Digital, Multimedia, Research

A recent study conducted by Otter , a leading Restaurant Operating System, has revealed figures on the financial impact of takeaway order cancellations for UK restaurants.

Key Points: 
  • A recent study conducted by Otter , a leading Restaurant Operating System, has revealed figures on the financial impact of takeaway order cancellations for UK restaurants.
  • The study found that the last hour of operation is a critical time for cancellations, with restaurants experiencing a 1.74x higher cancellation rate than those operating beyond this hour.
  • On average, 20% of orders and 31% of cancellations occur within the last hour before closing time.
  • In response to this challenge, Otter advocates for a review of restaurant operating hours and calls on businesses to establish buffer times to mitigate the clash between last-minute orders and closing schedules.

AquaBliss Introduces Revolutionary Cold Water Shower Filters to Enhance Wellness

Retrieved on: 
Thursday, April 4, 2024
Credible, Inflammation, Chlorine, Health, Burn, Vitamin C, Cold, Immunity, Depression, Science, Filtration, Metabolism, Credibility, Common, News, Carbon, Mineral, Skin, Water, Mindfulness, Injury, Pain, Nail, Plumbing

WILMINGTON, Del., April 4, 2024 /PRNewswire/ -- Can the right choice in shower filter deliver health benefits? The answer, backed by both science and in real world feedback is a strong yes. AquaBliss, a leading provider of innovative water filtration solutions, understands this well. In exciting news, the company recently announced the launch of its AquaBliss shower filters designed to help deliver the benefits of cold water therapy. As the demand for holistic wellness solutions grows, AquaBliss is answering the call by offering filters that enhance the advantages of cold showers.

Key Points: 
  • High-quality shower filters may also be able to enhance benefits of Cold Water Therapy.
  • In exciting news, the company recently announced the launch of its AquaBliss shower filters designed to help deliver the benefits of cold water therapy.
  • As the demand for holistic wellness solutions grows, AquaBliss is answering the call by offering filters that enhance the advantages of cold showers.
  • By filtering out these harsh chemicals AquaBliss filters boost the positive qualities of cold showers while also delivering benefits that would not be possible without these filters.

Kraus Hamdani Aerospace Wins Contract to Provide the U.S. Navy with Its First Electric VTOL Unmanned Aerial System (UAS)

Retrieved on: 
Thursday, April 4, 2024
Research, Intelligence, Navy, Common, Transport, University, UAS, Control, PMA

EMERYVILLE, Calif., April 4, 2024 /PRNewswire/ -- The U.S. Navy, through PMA 263, has chosen KHAero to provide its first electric, solar-powered VTOL UAS. It will be fielded by the United States Marine Corps Small Unit Remote Scouting System.

Key Points: 
  • U.S. Navy procures first-of-its-kind 100% electric, solar-powered Group 2 UAS from Kraus Hamdani Aerospace (KHAero), allowing them to radically simplify the operational footprint required
    EMERYVILLE, Calif., April 4, 2024 /PRNewswire/ -- The U.S. Navy, through PMA 263, has chosen KHAero to provide its first electric, solar-powered VTOL UAS.
  • It will be fielded by the United States Marine Corps Small Unit Remote Scouting System.
  • The Navy asked KHAero to demonstrate their offering through a comprehensive evaluation of capabilities.
  • Additionally, the Navy will get enhanced beyond line-of-sight communication capabilities, securing continued coverage in denied and contested environments.